October 2, 2022

The world’s first certified vegan paracetamol arrives in Germany

Reading time: 2 minutes

Developed by German pharmaceutical company Axunio, Paraveganio contains only plant-based ingredients and is the first product to receive vegan certification from the Vegan Society.

“By completely foregoing additives of animal origin, we guarantee a 100% vegan medicine, and have also had it officially certified by the Vegan Society – as the very first pharmaceutical company in the world!” says Axunio on his website.

Although paracetamol is one of the most popular over-the-counter pain relievers in the world, many are unaware that most paracetamol products contain an animal-derived additive called magnesium stearate.

Magnesium stearate, the magnesium salt of stearic acid, is commonly used for its lubricating properties for tablets and capsules in the pharmaceutical industry. It is stearic acid which is usually derived from animal fats.

Without ingredients of animal origin

Paraveganio is free from animal-derived magnesium stearate and instead contains pure vegetable-derived magnesium stearate.

The certified vegan pain reliever contains 500 mg of the proven active ingredient paracetamol. And just like other paracetamol products, it can be taken to help with fever, as well as to relieve mild to moderate pain.

Axunio wants to set an example and make conscious medication possible. Credit: Alamy Stock

According to the Vegan Society, around 75% of the most commonly prescribed medicines in the UK contain animal-derived ingredients. And of course many others are tested on animals before being approved for use.

“With the launch of our first certified vegan drug, we want to initiate a long-term overhaul of the pharmaceutical industry,” said Julia von Horsten, Head of Product and Business Development at Axunio.

Make more drugs vegan

The vegan certification represents a milestone moment for the Vegan Society.

The Vegan Society has been calling for the production of medicines without animals for many years. Its 2017 “Make More Medicines Vegan” campaign directly called on the UK government to create more alternatives for the growing vegan community.

“We are excited to see our Vegan brand for the first time on a vegan medicine. We know that many vegans struggle to find a drug that is both suitable for their needs and consistent with their beliefs, which can be a pain,” Ericka Durgahee, marketing manager for the Vegan Society, shared in a statement. Press.

Now available in Germany

While Paraveganio tablets are currently only available in Germany, Axunio plans to expand to other markets in the near future. To learn more about the vegan product, go to Axunio.